https://jcpr.in/index.php/journal <p align="justify">Journal of Clinical and Pharmaceutical Research (JCPR) is an international peer-reviewed online open-access journal that mainly publishes in all the aspects of Clinical and Pharmaceutical Research. This is a quarterly journal that publishes Research articles, Review articles, Short Communications and Case Reports from the areas but not limited to General Medicine, Anaesthesiology, Surgery, Orthopaedics, Neurology, Paediatrics, Psychiatry, ENT, Ophthalmology, Oncology, Gynaecology &amp; Obstetrics, Nephrology, Urology, Dermatology, Community Medicine, Public Health, Clinical Pharmacy, Pharmaceutics, Pharmacology, Pharmaceutical Analysis, Pharmaceutical Chemistry, Medicinal Chemistry, Pharmacognosy, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Pharmaceutical Technology, Novel Drug Delivery and Natural Products.</p> <p align="justify"><strong>PRIMARY INFORMATION</strong><br /><strong>Journal Title: </strong>Journal of Clinical and Pharmaceutical Research<br /><strong>Online ISSN: </strong>2583-2042</p> <p align="justify"><strong>Starting year: </strong>2021<br /><strong>Frequency of Publication: </strong>Quarterly<br /><strong>Publication format: </strong>Online (Open Access)<br /><strong>Language: </strong>English<br /><strong>Country: </strong>India</p> <p align="justify"><strong>Publisher: </strong>Universal Episteme Publications-India.<br /><strong>Email id: </strong>editor@jcpr.in<br /><strong>Mobile no: </strong>+91-9494632752</p> UNIVERSAL EPISTEME PUBLICATIONS en-US Journal of Clinical and Pharmaceutical Research 2583-2042 https://jcpr.in/index.php/journal/article/view/124 <p><strong>Aim:</strong> The main aim of this study is to assess the prevalence of various co-morbidities among the patients with chronic kidney disease.</p> <p><strong>Methods: </strong>This was a prospective study conducted for a period of six months at a tertiary care hospital of East Godavari district, Andhra Pradesh. Patients with both the genders who were diagnosed with CKD with an age of above 18 years were included and patients with acute renal failure were excluded from this study.</p> <p><strong>Results: </strong>In this study, most of the study participants were observed with stage-V CKD (80.4%) followed by stage-IV CKD (12.1%). Nephropathy due to hypertension (45.1%) and diabetes (24.3%) were observed to be the most common causes among the CKD patients in this study. Hypertension associated with diabetes (29.3%) was observed to be the most common co-morbidities in this study. Loop diuretics (43.7%) and calcium channel blockers (32.1%) were observed to be the most commonly prescribed anti-hypertensive drugs among the CKD patients associated with hypertension. Short acting insulin (71%) and sulfonyl ureas (13.1%) were observed to be the most commonly prescribed anti-diabetic drugs among the CKD patients associated with diabetes.</p> <p><strong>Conclusion: </strong>Routine screening and regular check-ups along with effective management of co-morbidities in CKD require a comprehensive approach that integrates the pharmacotherapy and inter-disciplinary collaboration. Clinical pharmacists should employ evidence-based practices, monitor drug interactions and advocate for patient-centred care to enhance the quality of life of CKD patients.</p> K. Pushpavalli S.T.P Prasuna V. Bhavana Priya Copyright (c) 2024 K. Pushpavalli, S.T.P Prasuna , V. Bhavana Priya https://creativecommons.org/licenses/by-nc/4.0 2024-07-31 2024-07-31 10.61427/jcpr.v4.i3.2024.124